Welcome to the latest edition of DNA Dispatch, the quarterly newsletter from OGT, your hybridization experts.
Hear from our esteemed speaker, Dr. Klaus Metzeler, MD, about his experience utilizing SureSeq™ Myeloid MRD panel to detect variants in key genes (e.g., NPM1 and FLT3-ITDs) often monitored in patients with myeloid malignancies.
Don't let back-orders slow you down. Contact us to order evaluation probes today and keep your lab moving.*
Featured probes:
First presented at the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo, read our latest scientific poster on targeted CNV NGS detection in CLL.
We are excited to announce our new partnership with Intelliseq, a genome informatic company and innovative provider of NGS analysis solutions – bringing you comprehensive genomic interpretation and greater insights into cancer research.
The role of the CytoCell® Field Application Scientist for technical customer support is a real differentiator – when was the last time you checked in with our experts?
Reach out to our team to schedule a FISH health check in 2024!
Download our crossword and try and find all of the hidden CytoSure® array words!
* This offer is only valid to new customers and existing customers not currently using any of the probes listed in the promotion. Offer valid until 31st December 2023. Additional restrictions may apply.